Study compares ketamine and electroconvulsive therapy for treatment-resistant depression, analyzing patient outcomes based on baseline characteristics and treatment settings.
The U.S. Food and Drug Administration issued draft guidance for drugmakers and medical device makers to improve diversity in clinical trials, emphasizing the importance of actions to support more equitable access to medical innovations.
The findings underscore the importance of recognizing anxiety as a potential prodromal symptom of Parkinson’s disease in clinical practice, potentially facilitating earlier diagnosis and intervention.
Cyberattack on Ascension hospitals across the U.S. compromises patient care, leading to medication errors, delayed lab results, and patient safety risks, as health workers struggle without access to critical electronic systems.
KFF Health News
Daily News
Stay up to date with the latest clinical headlines.
A call to action for the White House Initiative on Women's Health Research to prioritize critical research areas addressing the unique health needs of older women, who have been historically underrepresented in medical studies.
The Congressional Budget Office projects a rise in the uninsured rate to 8.9% by 2034, driven by immigration and policy changes affecting young adults, despite a record low of 7.2% in 2023.